Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05050591 · ClinicalTrials.gov registry record · NA
Evaluating the Clinical Effectiveness of a Patient-specific Silicone Stent
A NA study of Pulmonary Disease, Chronic Obstructive, sponsored by VisionAir Solutions.
- Active
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 2
- Study locations
NCT05050591: Active NA study of Pulmonary Disease, Chronic Obstructive, sponsored by VisionAir Solutions.
NCT05050591 is a NA study of Pulmonary Disease, Chronic Obstructive that is active but no longer recruiting, run by VisionAir Solutions. The registered enrollment target is 20 participants, below the 1,044-participant average among 74 other Pulmonary Disease, Chronic Obstructive trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05050591, a NA study of Pulmonary Disease, Chronic Obstructive, is active but no longer recruiting, sponsored by VisionAir Solutions.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of the trial is to establish a method, material, and patient-specific stent design that will last longer, fit better, and cause less trauma to the airway and the patient.
Primary Outcome
Change in BDI/TDI over course of study
Conditions Studied
Interventions
- DEVICE Patient-Specific Silicone Airway Stent
Study Locations (2)
Minnesota
- Mayo Clinic - Rochester
Ohio
- Pulmonary Medicine - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-08-05 |
| Est. Completion | 2025-07 |
| Phase | NA |
What the registry record for NCT05050591 still lists
NCT05050591 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,044-participant average among 74 other Pulmonary Disease, Chronic Obstructive trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Pulmonary Disease, Chronic Obstructive appearing as the primary indexed condition, and to 1 intervention - of which Patient-Specific Silicone Airway Stent is the first listed.
NCT05050591 reports a single indexed study location in Minnesota, Ohio.
Frequently Asked Questions
What is clinical trial NCT05050591 about?
NCT05050591 is a clinical study titled "Evaluating the Clinical Effectiveness of a Patient-specific Silicone Stent". The goal of the trial is to establish a method, material, and patient-specific stent design that will last longer, fit better, and cause less trauma to the airway and the patient.
What is the current status of trial NCT05050591?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2021-08-05. Estimated completion is 2025-07.
What conditions does trial NCT05050591 study?
This clinical trial studies the following conditions: Pulmonary Disease, Chronic Obstructive.
What interventions are being tested in trial NCT05050591?
The interventions under investigation include: Patient-Specific Silicone Airway Stent (DEVICE).
Who is sponsoring clinical trial NCT05050591?
This trial is sponsored by VisionAir Solutions, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05050591 being conducted?
This trial has 2 study locations across Minnesota, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Disease, Chronic Obstructive
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05050591's enrollment target sits among peer trials
20 69th of 74 higher than 5 of 74 other Pulmonary Disease, Chronic Obstructive trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pulmonary Disease, Chronic Obstructive trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pragmatic Trial to Enhance Quality Safety, and Patient Experience in COPD
RECRUITING · NA
-
Air Filtration for COPD in VA Population of Veterans
ACTIVE NOT RECRUITING · NA
-
Outlook: An Intervention to Improve Quality of Life in Serious Illness
COMPLETED · NA
-
Oxygen Savings With Administered Oxygen and High Flow Ambient Air At Rest
COMPLETED · NA
-
Problem-Solving Therapy for People With Major Depression and Chronic Obstructive Pulmonary Disease
COMPLETED · NA
-
Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI